The data of the present work along with the results on CYP46A1 inhibition in a mouse model of Alzheimer's disease [82] highlight a new link between the CYP46A1 deficiency and Alzheimer’s disease, namely abnormal phosphorylation of neuronal cytoskeletal proteins. This evidence concerns the gene CYP46A1 and Alzheimer disease.